Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors

Clinical trial NCT02897778 · COMPLETED

Trial details

NCT number: NCT02897778
Sponsor: Syndax Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasms Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type Bronchial Neoplasms Lung Neoplasms Respiratory Tract Neoplasms Thoracic Neoplasms Digestive System Neoplasms Endocrine Gland Neoplasms Carcinoma, Non-Small-Cell Lung Lung Diseases Breast Neoplasms

Start date: 2016-08-24
Primary completion: 2017-03-13
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.